Target Therapy on Tumors in HER2-positive Breast Cancer Patients Boosts Longevity

by Trilok Kapur on  December 14, 2009 at 11:16 AM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

 Target Therapy on Tumors in HER2-positive Breast Cancer Patients Boosts Longevity
Targeted therapy on tumors in cases of HER2-positive breast cancer is more effective , according to experts.

Kimberly Blackwell, M.D., associate professor of medicine at Duke University Medical Center, insisted Lapatinib plus trastuzumab are significantly better than lapatinib alone in extending the lives of breast cancer patients whose tumors are HER2-positive.

He noted that the patients undergoing combination targeted therapy had a four-month survival advantage over those who took lapatinib alone.

She said: "This is the first time that a pair of targeted therapies has been shown to be superior to any intervention that paired a targeted therapy with a hormonal or chemotherapy based approach."

As part of the study, a large, Phase III clinical trial was conducted.

As part of the trial, the investigators randomized 296 patients with metastatic breast cancer to receive either lapatinib (also known as Tykerb) alone or lapatinib plus trastuzumab (Herceptin) once a day.

All participants had metastatic disease that had continued to spread even after treatments with several interventions that included trastuzumab plus chemotherapy.

Trastuzumab blocks part of the HER2 growth factor that appears on the surface of some breast cancer cells while lapatinib binds to a second growth factor, EGFR, and part of HER2 that sits below the cell surface.

Clackwell explained: "It's sort of a double whammy, disabling the HER2 protein in two places instead of one."

The study noted that the median overall survival following treatment with lapatinib plus trastuzumab was 60.7 weeks compared to 41.4 weeks for those who took only lapatinib.

Source: ANI
TRI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Women and Cancer Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Reiki and Pranic Healing Breast Cancer Facts Cancer Facts Tips to Live Longer Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive